IFIT3 Associates with m⁶A-Modified RNA to Restrict Hepatitis C Virus Infection
Matthew G. Thompson, Moonhee Park, Netanya S. Schlamowitz, Matthew R. Lanahan, Yunsun Nam, Stacy M. Horner
This paper identifies IFIT3's preference for m⁶A-modified RNA to restrict HCV infection and reveals structural regions critical for RNA binding and antiviral activity.
bioRxiv · Mar 26, 2026 · PreprintImmunology